115 related articles for article (PubMed ID: 4038476)
1. Intravenous and standard immune serum globulin preparations interfere with uptake of 125I-C3 onto sensitized erythrocytes and inhibit hemolytic complement activity.
Berger M; Rosenkranz P; Brown CY
Clin Immunol Immunopathol; 1985 Feb; 34(2):227-36. PubMed ID: 4038476
[TBL] [Abstract][Full Text] [Related]
2. The interaction of immune serum globulin and immune globulin intravenous with complement.
Bing DH
Mol Immunol; 1983 Aug; 20(8):893-900. PubMed ID: 6604863
[TBL] [Abstract][Full Text] [Related]
3. High doses of intravenous Ig inhibit in vitro uptake of C4 fragments onto sensitized erythrocytes.
Basta M; Fries LF; Frank MM
Blood; 1991 Jan; 77(2):376-80. PubMed ID: 1985703
[TBL] [Abstract][Full Text] [Related]
4. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
5. Regulation of complement activity by immunoglobulin. I. Effect of immunoglobulin isotype on C4 uptake on antibody-sensitized sheep erythrocytes and solid phase immune complexes.
Miletic VD; Hester CG; Frank MM
J Immunol; 1996 Jan; 156(2):749-57. PubMed ID: 8543829
[TBL] [Abstract][Full Text] [Related]
6. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
Newman SL; Mikus LK
J Exp Med; 1985 Jun; 161(6):1414-31. PubMed ID: 2409200
[TBL] [Abstract][Full Text] [Related]
7. A new concept for the effector mechanism of intravenous immunoglobulin in hemocytopenias.
Mueller-Eckhardt C; Salama A; Kiefel V; Küenzlen E; Förster C
Blut; 1984 Jun; 48(6):353-6. PubMed ID: 6540128
[No Abstract] [Full Text] [Related]
8. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
Schreiber AD; Frank MM
J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
[TBL] [Abstract][Full Text] [Related]
9. Interaction of desialated guinea pig erythrocytes with the classical and alternative pathways of guinea pig complement in vivo and in vitro.
Brown EJ; Joiner KA; Frank MM
J Clin Invest; 1983 Jun; 71(6):1710-9. PubMed ID: 6863540
[TBL] [Abstract][Full Text] [Related]
10. Complement interaction with immune serum globulin and immune globulin intravenous.
Bing DH
Am J Med; 1984 Mar; 76(3A):19-24. PubMed ID: 6424450
[TBL] [Abstract][Full Text] [Related]
11. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
[TBL] [Abstract][Full Text] [Related]
12. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
Mayes JT; Schreiber RD; Cooper NR
J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of complement by covalent attachment of rosmarinic acid to activated C3b.
Sahu A; Rawal N; Pangburn MK
Biochem Pharmacol; 1999 Jun; 57(12):1439-46. PubMed ID: 10353266
[TBL] [Abstract][Full Text] [Related]
14. A new activity of complement component C3: cell-bound C3b potentiates lysis of erythrocytes by C5b,6 and terminal components.
Hammer CH; Abramovitz AS; Mayer MM
J Immunol; 1976 Sep; 117(3):830-4. PubMed ID: 956655
[TBL] [Abstract][Full Text] [Related]
15. Hemolysis after intravenous immune globulin therapy: relation to IgG subclasses of red cell antibody.
Okubo S; Ishida T; Yasunaga K
Transfusion; 1990 Jun; 30(5):436-8. PubMed ID: 2360236
[TBL] [Abstract][Full Text] [Related]
16. A simple alternative pathway for hemolytic assay of human complement component C3 using methylamine-treated plasma.
Jessen TE; Barkholt V; Welinder KG
J Immunol Methods; 1983 May; 60(1-2):89-100. PubMed ID: 6406606
[TBL] [Abstract][Full Text] [Related]
17. Effect of intravenous immunoglobulin in immune thrombocytopenia.
Salama A; Mueller-Eckhardt C; Kiefel V
Lancet; 1983 Jul; 2(8343):193-5. PubMed ID: 6135031
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analyses of the relationship between C3 consumption, C3b capture, and immune adherence of complement-fixing antibody/DNA immune complexes.
Edberg JC; Tosic L; Wright EL; Sutherland WM; Taylor RP
J Immunol; 1988 Dec; 141(12):4258-65. PubMed ID: 3198918
[TBL] [Abstract][Full Text] [Related]
19. Sheep Erythrocyte Preparation for Hemolytic Tests Exploring Complement Functional Activities.
Chabannes M; Bordereau P; Martins PV; Dragon-Durey MA
Methods Mol Biol; 2021; 2227():61-67. PubMed ID: 33847931
[TBL] [Abstract][Full Text] [Related]
20. Complement activation in vitro by antiplatelet antibodies in chronic immune thrombocytopenic purpura.
Tsubakio T; Tani P; Curd JG; McMillan R
Br J Haematol; 1986 Jun; 63(2):293-300. PubMed ID: 3718872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
